1Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract,2010,87:4-14.
2Pan CY,Jin SW.Prevalence of Type 2 Diabetes Mellitus.Chin J Endiocrinol Metab,2005,21:S1-S5.
3Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-101.
4White SL,Polkinghome KR,Cass A,et al.Limited knowledge of kidney disease in a survey of AusDiab study participants.Med J Aust,2008,188:204-208.
5National Kidney Foundation.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.Am J Kidney Dis,2007,50:S1-S179.
6McDonald S,Excell L,Livingston B.Appendix Ⅱ.In:ANZDATA Registry Report 2008.Adelaide:Australia and New Zealand Dialysis and Transplant Resistry,2008:1-97.
7Yamagata K,lseki K,Nitta K,et al.Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.Clin Exp Nephrol,2008,12:1-8.
8Polenakovic M,Sikole A,Nikolov IG,et al.Diabetics on dialysis in the republic of macedonia:a nationwide epidemiological study.Prilozi,2010,31:261-277.
10Olsen S,Mogensen CE.How often is NIDDM complicated with Non-diabetic renal disease? An analysis of renal biop sies and the literature.Diabetologia,1996,39:1638-1645.
7Ravid M,Savin H,Jutrin I,Bet al.Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type 2 diabietic patients.Am Intern Med,1993,118:577-581.
